Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania Donovani

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00030-11
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Genetic Heterogeneity in Clinical Isolates of Leishmania Donovani From India

Journal of Clinical Microbiology
Microbiology
2011English

In Vitro Synergistic Effect of Amphotericin B and Allicin on Leishmania Donovani and L. Infantum

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

Role of Aquaglyceroporin (AQP1) Gene and Drug Uptake in Antimony-Resistant Clinical Isolates of Leishmania Donovani

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2008English

In Vitro Interactions of Micafungin With Amphotericin B Against Clinical Isolates of Candida Spp.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

In Vitro Activity of Amphotericin B Cochleates Against Leishmania Chagasi

Memorias do Instituto Oswaldo Cruz
MedicineMicrobiology
2011English

Leishmania Donovani and Leishmania Tropica

BMJ
1912English

Amphotericin B: Spectrum and Resistance

Journal of Antimicrobial Chemotherapy
Infectious DiseasesMicrobiologyPharmacology
2002English

Leishmania Donovani in the Peripheral Blood

Experimental Biology and Medicine
MedicineBiochemistryGeneticsMolecular Biology
1923English

New Insight Into Amphotericin B Resistance in Aspergillus Terreus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy